(Q73068639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

G Huhle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Abletshauser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

N Mayer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

G Weidinger

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D L Heene

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

229-234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

High-dose fluvastatin and bezafibrate combination treatment for heterozygous familial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

Efficacy of a low dose-range of fluvastatin (XU 62-320) in the treatment of primary hypercholesterolaemia. A dose-response study in 431 patients. The French-Dutch Fluvastatin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

Increased fibrinogen binding to platelets from patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

Platelet formation of 12-hydroxyeicosatetraenoic acid and thromboxane B2 is increased in type IIA hypercholesterolemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

Increased platelet sensitivity and thromboxane B2formation in type-II hyperlipoproteinaemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

The actions of lovastatin on platelet function and platelet eicosanoid receptors in type II hypercholesterolaemia. A double-blind, placebo-controlled, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

Platelet membrane fluidity in type IIA, type IIB and type IV hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

A review of current clinical findings with fluvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2899%2900037-7

7 January 2021

10.1016/S0049-3848(99)00037-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10515287%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference